Comparison of Solid Tumor Treatment Response Observed in Clinical Practice With Response Reported in Clinical Trials
Author:
Affiliation:
1. Cardinal Health Specialty Solutions, Dublin, Ohio
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2776898/feinberg_2021_oi_201101_1613710255.45739.pdf
Reference28 articles.
1. Use of real-world evidence to support FDA approval of oncology drugs.;Feinberg;Value Health,2020
2. Finding the evidence in real-world evidence: moving from data to information to knowledge.;Schilsky;J Am Coll Surg,2017
3. surrogate end points and patient-reported outcomes for novel oncology drugs approved between 2011 and 2017.;Zettler;JAMA Oncol,2019
4. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).;Eisenhauer;Eur J Cancer,2009
5. Generating real-world tumor burden endpoints from electronic health record data: comparison of RECIST, radiology-anchored, and clinician-anchored approaches for abstracting real-world progression in non-small cell lung cancer.;Griffith;Adv Ther,2019
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transforming breast cancer management with real-world data and artificial intelligence;ESMO Real World Data and Digital Oncology;2024-09
2. Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US;The Oncologist;2024-08-21
3. Real-World Outcomes in Patients with Advanced/Metastatic Renal Cell Carcinoma Receiving Cabozantinib or Other Tyrosine Kinase Inhibitors After Checkpoint Inhibitor-Based Therapy;Kidney Cancer;2024-08-02
4. Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation;Cancer Imaging;2024-06-07
5. Real-world outcomes associated with afatinib use in patients with solid tumors harboring NRG1 gene fusions;Lung Cancer;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3